XML 58 R34.htm IDEA: XBRL DOCUMENT v3.20.4
Revenue Recognition (Tables)
 12 Months Ended
Dec. 31, 2020
Revenue from External Customer [Line Items]  
Contract with customer balances The following table provides information about contract assets from contracts with customers (in millions):
Balance Sheet LocationDecember 31,
2020		December 31,
2019
Short-term contract assetsPrepaid expenses and other current assets$19.7 $26.3 
Product  
Revenue from External Customer [Line Items]  
Disaggregation of revenue We generated net sales in the following geographic locations(1) during each of the periods presented below (in millions):
Year Ended
December 31,
2020		December 31,
2019		December 31,
2018
U.S.$3,441.1 $3,225.6 $3,098.3 
Europe(2)
1,350.6 1,335.8 1,347.6 
All other countries(3)
271.6 276.0 285.8 
Total net sales$5,063.3 $4,837.4 $4,731.7 

(1)    The net sales by geography is derived from the location of the entity that sells to a third party.
(2)    Includes Ireland net sales of $29.8 million, $23.4 million, and $25.7 million for the years ended December 31, 2020, December 31, 2019, and December 31, 2018, respectively.
(3)    Includes revenue generated primarily in Israel, Mexico, Australia, and Canada.
    
Product Category

    The following is a summary of our net sales by category (in millions):

Year Ended
December 31, 2020December 31, 2019December 31,
2018
CSCA(1)
Upper respiratory$489.5 $515.2 $492.5 
Digestive health452.6 413.9 403.6 
Pain and sleep-aids424.7 383.6 388.1 
Nutrition387.4 394.4 432.4 
Healthy lifestyle348.5 352.4 333.6 
Oral self-care284.6 106.4 — 
Skincare and personal hygiene191.8 182.9 164.1 
Vitamins, minerals, and supplements27.0 28.6 26.1 
Animal health— 43.7 93.9 
Other CSCA(2)
86.9 66.6 77.3 
Total CSCA2,693.0 2,487.7 2,411.6 
CSCI
Skincare and personal hygiene351.8 371.6 396.5 
Upper respiratory255.1 276.8 276.5 
Vitamins, minerals, and supplements201.0 180.2 187.2 
Pain and sleep-aids190.4 167.9 170.0 
Healthy lifestyle165.4 173.8 180.7 
Oral self-care97.8 51.2 8.9 
Digestive health26.5 27.1 29.5 
Other CSCI(3)
107.2 133.6 150.0 
Total CSCI1,395.2 1,382.2 1,399.3 
RX975.1 967.5 920.8 
Total net sales$5,063.3 $4,837.4 $4,731.7 

(1)    Includes net sales from our OTC contract manufacturing business.
(2)    Consists primarily of diagnostic products and other miscellaneous or otherwise uncategorized product lines and markets, none of which is greater than 10% of the segment net sales.
(3)    Consists primarily of liquid licensed products, our distribution business and other miscellaneous or otherwise uncategorized product lines and markets, none of which is greater than 10% of the segment net sales.